dc.contributor.author | CAFFREY, MARTIN | en |
dc.contributor.author | CAFFREY, MARTIN | en |
dc.date.accessioned | 2015-12-09T12:35:33Z | |
dc.date.available | 2015-12-09T12:35:33Z | |
dc.date.created | 2015 | en |
dc.date.issued | 2015 | en |
dc.date.submitted | 2015 | en |
dc.identifier.citation | Fowler P.W, Orwick-Rydmark M, Radestock S, Solcan N, Dijkman P.M, Lyons J.A, Kwok J, Caffrey M, Watts A, Forrest L.R, Newstead S, Gating topology of the proton-coupled oligopeptide symporters, Structure, 23, 2, 2015, 290 - 301 | en |
dc.identifier.other | Y | en |
dc.description | PUBLISHED | en |
dc.description | Cited By :1 Export Date: 19 August 2015 | en |
dc.description.abstract | Peptide transport is the main route through which the body absorbs and retains dietary protein and hence plays an important role in human physiology (Steinhardt and Adibi, 1986). The combined action of acid hydrolysis in the stomach and nonspecific peptidases in the small intestine breaks down ingested protein into peptide fragments and free amino acids. The resulting di- and tripeptides are then actively transported across the intestinal brush border membrane by the integral membrane peptide transporter, PepT1 (Fei et al., 1994 and Leibach and Ganapathy, 1996). PepT1 recognizes a diverse range of small peptides and is also responsible for the absorption of many orally administered drugs, including β-lactam antibiotics and a growing number of peptiditic prodrugs (Luckner and Brandsch, 2005, Pieri et al., 2009 and Brandsch, 2009). We do not yet fully understand the mechanism by which PepT1 recognizes and transports molecules into the cell, and this lack of knowledge is hampering the modification of drugs to improve their pharmacokinetic profiles. | en |
dc.description.sponsorship | P.W.F. is funded by the Wellcome Trust through grant 092970/Z/10/Z. S.N. is a Wellcome Trust Investigator (102890/Z/13/Z) and is grateful to the Medical Research Council (MRC) for a Career Development Award (G0900399). L.F. thanks the Max Planck Society and the Intramural Research Program of the NIH, NINDS for funding. A.W. gratefully acknowledges financial support from the MRC (G0900076/1) for P.D., from the EPSRC (EP/F068085/1) for M.O.-R., and Jeffrey Harmer and Chris Timmel for advice and access to the EPSRC CAESR-Oxford ESR facility. M.C. is funded by Science Foundation Ireland (07/IN.1/B1836, 12/IA/1255), FP7 COST Action CM0902, and the NIH (P50GM073210, U54GM094599). J.A.L. is funded by the Danish Council for Independent Research in Natural Sciences. We also thank the beamline staff at the Diamond Light Source Ltd., UK (I24) and T. Shah for lipid synthesis. N.S. was funded through the Wellcome Trust Structural Biology DPhil program. We are grateful to Vladimir Kasho and Wayne Hubbell for providing the LacY DEER data | en |
dc.format.extent | 290 | en |
dc.format.extent | 301 | en |
dc.relation.ispartofseries | Structure | en |
dc.relation.ispartofseries | 23 | en |
dc.relation.ispartofseries | 2 | en |
dc.rights | Y | en |
dc.subject | Peptide transport | en |
dc.subject.lcsh | Peptide transport | en |
dc.title | Gating topology of the proton-coupled oligopeptide symporters | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/mcaffre | en |
dc.identifier.rssinternalid | 105478 | en |
dc.identifier.doi | http://dx.doi.org/10.1016/j.str.2014.12.012 | en |
dc.rights.ecaccessrights | openAccess | |
dc.identifier.rssuri | http://www.scopus.com/inward/record.url?eid=2-s2.0-84930190324&partnerID=40&md5=60df51aea4cb0204d0422ceed3e29ada | en |
dc.contributor.sponsor | Science Foundation Ireland (SFI) | en |
dc.contributor.sponsorGrantNumber | 12/IA/1255 | en |
dc.contributor.sponsor | Science Foundation Ireland (SFI) | en |
dc.contributor.sponsorGrantNumber | 07/IN.1/B1836 | en |
dc.identifier.uri | http://hdl.handle.net/2262/75225 | |